Ionis Pharmaceuticals (IONS) Operating Income Growth (5y) (2014 - 2026)

Ionis Pharmaceuticals (IONS) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 69,146.49 Bn 69,146.20 Bn -
2 Nanobiotix 1,942.19 Bn 1,942.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 475.42 Bn 470.63 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.32 Bn 116.08 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.80 Bn 61.04 Bn 3.31 Bn
7 Belite Bio 63.28 Bn 63.28 Bn -
8 Argenx Se 56.67 Bn 51.48 Bn 1.41 Bn
9 Revolution Medicines 38.15 Bn 38.15 Bn -
10 Ionis Pharmaceuticals 9.37 Bn 7.45 Bn 243.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.01%
Dec 31, 2025 -56.75%
Sep 30, 2025 -34.39%
Jun 30, 2025 36.29%
Mar 31, 2025 -19.16%
Dec 31, 2024 -19.38%
Sep 30, 2024 -127.48%
Jun 30, 2024 -28.55%
Mar 31, 2024 -26.43%
Dec 31, 2023 -20.76%
Sep 30, 2023 -50.47%
Jun 30, 2023 -12.40%
Mar 31, 2023 -103.13%
Dec 31, 2022 -101.90%
Sep 30, 2022 -48.53%
Jun 30, 2022 -72.46%
Mar 31, 2022 -37.70%
Dec 31, 2021 39.91%
Sep 30, 2021 -48.94%
Jun 30, 2021 -8.32%